Early introduction of tolvaptan after cardiac surgery: a renal sparing strategy in the light of the renal resistive index measured by ultrasound

BACKGROUND: Renal failure is a serious complication after cardiac surgery, which can be caused by long-term intravenous (IV) loop diuretic use. Tolvaptan is an oral selective vasopressin-2 receptor antagonist used in patients irresponsive to loop diuretics. We investigated their renal perfusion chan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Tomoko S., Ono, Shunya, Kajimoto, Kan, Kuwaki, Kenji, Yamamoto, Taira, Amano, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631092/
https://www.ncbi.nlm.nih.gov/pubmed/26525900
http://dx.doi.org/10.1186/s13019-015-0372-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631092/
https://www.ncbi.nlm.nih.gov/pubmed/26525900
http://dx.doi.org/10.1186/s13019-015-0372-0

Ejemplares similares